Fate Therapeutics (FATE) is the lead sponsor of 4 active clinical trials listed on ClinicalTrials.gov[2], including 4 Phase 1[1].
No Form 4 insider filings for FATE were recorded at the SEC in the past 30 days[3].
FATE is tracked by BiotechSigns with a current catalyst score of 62/100 and grade C. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
Fate Therapeutics (FATE) is the lead sponsor of 4 active clinical trials listed on ClinicalTrials.gov[2], including 4 Phase 1[1].
No Form 4 insider filings for FATE were recorded at the SEC in the past 30 days[3].